Compugen Ltd.
ILDR2 ANTAGONISTS AND COMBINATIONS THEREOF
Last updated:
Abstract:
The present invention relates to a novel pharmaceutical combination comprising an ILDR2 antagonist according to any of the aforementioned claims, plus one or more other therapeutically active compounds, and to novel specific ILDR2 antagonists.
Status:
Application
Type:
Utility
Filling date:
28 Nov 2018
Issue date:
26 Nov 2020